[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100562505":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":27,"centralContacts":32,"locations":42,"responsibleParty":92,"collaborators":10,"id":94,"slug":95,"hasResults":96,"nctId":97,"briefTitle":98,"officialTitle":99,"acronym":100,"eligibilityCriteria":101,"healthyVolunteers":96,"sex":102,"minAge":10,"maxAge":10,"enrollmentInfo":103,"targetDuration":10,"studyType":106,"phases":10,"briefSummary":107,"conditions":108,"keywords":10,"overallStatus":45,"whyStopped":10,"lastUpdateSubmitDate":110,"lastUpdatePostDateStruct":111,"startDateStruct":114,"completionDateStruct":116,"leadSponsor":118,"locationsCount":119},{"fullName":5,"class":6},"Teleflex","INDUSTRY",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Subject",null,"Needing a vascular access device for therapy or diagnosis",[13],"Device: Central venous catheter",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":20},"DEVICE","Central venous catheter","Placement of a medical device to gain entry into the bloodstream, typically through a vein or artery, for the purpose of administering fluids, medications, blood products, or for hemodialysis",[9],[21,22,23,24,25,26],"Peripherally inserted central catheter","Dialysis catheter","Midline intravenous catheter","Peripheral intravenous catheter","Arterial catheter","Catheter navigation\u002Ftip confirmation device",[28],{"name":29,"affiliation":30,"role":31},"Amy Bardin","Teleflex Incorporated Clinical and Medical Affairs","STUDY_DIRECTOR",[33,38],{"name":34,"role":35,"phone":36,"phoneExt":10,"email":37},"Aderinola (Derin) Ogundimu, PhD, ACRP, PMP","CONTACT","469.569.9223","aderinola.ogundimu@teleflex.com",{"name":39,"role":35,"phone":40,"phoneExt":10,"email":41},"Thomas E. Philbeck, Jr., PhD","2107227438","thomas.philbeck@teleflex.com",[43,61,78],{"facility":44,"status":45,"city":46,"state":47,"zip":48,"country":49,"countryCode":50,"cosmosGeoPoint":51,"geoPoint":56,"contacts":57},"Huntsville Hospital","RECRUITING","Huntsville","Alabama","35801","United States","US",{"type":52,"coordinates":53},"Point",[54,55],-86.58594,34.7304,{"lat":55,"lon":54},[58],{"name":59,"role":35,"phone":10,"phoneExt":10,"email":60},"Sara Couey, DNP, CRNP","sara.couey@hhsys.org",{"facility":62,"status":45,"city":63,"state":64,"zip":65,"country":49,"countryCode":50,"cosmosGeoPoint":66,"geoPoint":70,"contacts":71},"Loma Linda University Health","Loma Linda","California","92354",{"type":52,"coordinates":67},[68,69],-117.26115,34.04835,{"lat":69,"lon":68},[72,75],{"name":73,"role":35,"phone":10,"phoneExt":10,"email":74},"Melissa McCabe, MD, MSCR","mmccabe@llu.edu",{"name":76,"role":35,"phone":10,"phoneExt":10,"email":77},"Sarah Capalla, MSN, RN","scapalla@llu.edu",{"facility":79,"status":45,"city":80,"state":81,"zip":82,"country":49,"countryCode":50,"cosmosGeoPoint":83,"geoPoint":87,"contacts":88},"Tufts Medical Center","Boston","Massachusetts","02111",{"type":52,"coordinates":84},[85,86],-71.05977,42.35843,{"lat":86,"lon":85},[89],{"name":90,"role":35,"phone":10,"phoneExt":10,"email":91},"Haval Chweich, MD","haval.chweich1@tuftsmedicine.org",{"type":93,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100562505","a-clinical-registry-to-demonstrate-the-safety-and-performance-of-teleflex-vascular-access-devices-100562505",false,"NCT06604039","A Clinical Registry to Demonstrate the Safety and Performance of Teleflex Vascular Access Devices","A Prospective Clinical Registry Evaluating Safety and Performance of Teleflex Vascular Access Devices","VADER","Inclusion Criteria:\n\n* Subjects will undergo a procedure that will include use of a Teleflex device covered by this Research.\n* Subject is willing and capable of providing informed consent and\u002For give approval to collect, store and process limited health information by the Sponsor; or such consent is provided by a legally designated representative if required by local law or regulation.\n* Subjects is able to read and understand English or Spanish languages\n\nExclusion Criteria:\n\n* Subject is currently participating in another clinical Registry or investigation that may confound the results of this Registry.\n* Subject was previously failed screening or was enrolled in this clinical Registry.\n* Subject is imprisoned\n* Subject is cognitively impaired and unable to provide informed consent","ALL",{"count":104,"type":105},2500,"ESTIMATED","OBSERVATIONAL","The general objective of Teleflex's Vascular Access Device Registry (VADER) is to provide high-quality Level 3 (or better) data on the performance, safety and clinical benefits of Teleflex's vascular access devices when used in a real-world setting",[109],"Vascular Access Device","2025-08-01",{"date":112,"type":113},"2025-08-07","ACTUAL",{"date":115,"type":113},"2024-12-08",{"date":117,"type":105},"2034-12-07",{"name":5,"class":6},3]